NLSPW β€” NLS PHARMACEUTICS LTD

Ownership history in UBS Group AG  Β·  10 quarters on record

This page tracks every 13F SEC filing in which UBS Group AG reported a position in NLS PHARMACEUTICS LTD (NLSPW). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

% of Fund (quarterly)    NLSPW price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 10 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 424 -5,599 -93.0% 0.00% $8 β€”
2024 Q1 ADDED 6,023 +5,023 +502.3% 0.00% $295 β€”
2023 Q4 REDUCED 1,000 -2,745 -73.3% 0.00% $55 β€”
2022 Q4 REDUCED 3,745 -11,802 -75.9% 0.00% $1K β€”
2022 Q3 ADDED 15,547 +13,557 +681.3% 0.00% $4K β€”
2022 Q1 REDUCED 1,990 -645 -24.5% 0.00% $1K β€”
2021 Q4 UNCHANGED 2,635 β€” 0% 0.00% $1K β€”
2021 Q3 REDUCED 2,635 -711 -21.2% 0.00% $2K β€”
2021 Q2 ADDED 3,346 +227 +7.3% 0.00% $3K β€”
2021 Q1 INITIATED 3,119 β€” β€” 0.00% $3K β€”

🏒 Other funds also holding NLSPW

As of 2025 Q3 β€” sorted by position size

SUSQUEHANNA INTERNATIONAL GROUP, LLP 3Y 7Y 0.0%
← Back to UBS Group AG Holdings